NCP and Nobel AFF
21.07.2023
On July 21, 2023, the Secretariat of the Kazakh National Contact Point (hereinafter - NCP) represented by the Economic Research Institute JSC (ERI) held a meeting with Nobel Almaty Pharmaceutical Factory JSC (hereinafter - Nobel). The meeting was attended by the Director of the NCP Secretariat A. Kasenova, Deputy Director of the Center I. Beisekeyeva, Leading Expert G. Makanova, and Project Assistant A. Musina. On Nobel's side, managers and staff from the Department of Hospital Sector Development and the Legal Department were present. During the meeting, the representatives of the Secretariat presented the current work, activities and functioning of the Kazakhstan NCPs, and elaborated on the OECD International Standards and the OECD Guidelines for Multinational Enterprises. In turn, Nobel expressed interest in the activities of the NCP, as well as readiness for the implementation and dissemination of the OECD Guidelines. In conclusion, the parties expressed interest in further exploring the standards proposed by the OECD to create an environment for responsible business conduct in line with international best practices, as the activities of multinational enterprises often span several countries and different cultural, legal and regulatory environments. Additionally, more businesses are responding by adopting responsible business practices, facilitating dialog and engaging with stakeholders. For reference: The NCP is a collegial advisory body that makes decisions on pending appeals regarding violations of the OECD Guidelines for Multinational Enterprises, including disclosure, human rights, labor and industrial relations, anti-bribery, bribery and extortion, environmental protection, consumer interests, science and technology, competition and taxation. Nobel AFF JSC is a leading domestic manufacturer of pharmaceuticals in Kazakhstan with expanding operations in the CIS.
Views: 1742 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
